Skip Nav Destination
Issues
May – June 1999
ISSN 0302-2838
EISSN 1873-7560
In this Issue
European Urology 1999, Vol. 35, No. 5-6
Contents
Vol. 35, 1999
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): I–IV.
https://doi.org/10.1159/000019903
Strategies for the Chemoprevention of Prostate Cancer
Contents Vol. 35, No. 5–6, 1999
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 337–340.
https://doi.org/10.1159/000019904
Introduction
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 341.
https://doi.org/10.1159/000019905
Paper
Chemoprevention of Prostate Cancer: Concepts and Strategies
Subject Area:
Further Areas
Gary J. Kelloff; Ronald Lieberman; Vernon E. Steele; Charles W. Boone; Ronald A. Lubet; Levy Kopelovitch; Winfred A. Malone; James A. Crowell; Caroline C. Sigman
European Urology (1999) 35 (5-6): 342–350.
https://doi.org/10.1159/000019906
Genetic and Environmental Factors in Prostate Cancer Genesis
Molecular Biology of Progression of Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 351–354.
https://doi.org/10.1159/000019907
Further Section
Congress Calendar
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 354.
https://doi.org/10.1159/000019908
Genetic and Environmental Factors in Prostate Cancer Genesis
Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility
Subject Area:
Further Areas
R.K. Ross; G.A. Coetzee; C.L. Pearce; J.K.V. Reichardt; P. Bretsky; L.N. Kolonel; B.E. Henderson; E. Lander; D. Altshuler; G. Daley
European Urology (1999) 35 (5-6): 355–361.
https://doi.org/10.1159/000019909
Genetic and Environmental Factors in Prostate Cancer Genesis:Identifying High-Risk Cohorts
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 362–369.
https://doi.org/10.1159/000019910
Epidemiology of Prostate Cancer Chemoprevention
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 370–376.
https://doi.org/10.1159/000019911
Diet and Its Preventive Role in Prostatic Disease
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 377–387.
https://doi.org/10.1159/000019912
Dietary Fat and Prostate Cancer Progression and Survival
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 388–391.
https://doi.org/10.1159/000019913
Molecular Targets for Chemoprevention of Prostate Cancer
Vitamin D and Prostate Cancer Risk
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 392–394.
https://doi.org/10.1159/000019914
Lipoxygenase Inhibition in Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 395–398.
https://doi.org/10.1159/000019915
Angiogenesis, p53, bcl-2 and Ki-67 in the Progression of Prostate Cancer after Radical Prostatectomy
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 399–407.
https://doi.org/10.1159/000019916
Changes in Gene Expression and Targets for Therapy
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 408–412.
https://doi.org/10.1159/000019917
Mechanism of Androgen Receptor Activation and Possible Implications for Chemoprevention Trials
Subject Area:
Further Areas
Helmut Klocker; Zoran Culig; Iris E. Eder; Claudia Nessler-Menardi; Alfred Hobisch; Thomas Putz; Georg Bartsch; Heike Peterziel; Andrew C.B. Cato
European Urology (1999) 35 (5-6): 413–419.
https://doi.org/10.1159/000019918
New Agents for Chemoprevention of Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 420–423.
https://doi.org/10.1159/000019873
Retinoids in Chemoprevention
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 424–428.
https://doi.org/10.1159/000019874
Evaluation of Biomarker Modulation by Fenretinide in Prostate Cancer Patients
Subject Area:
Further Areas
D. Urban; R. Myers; U. Manne; H. Weiss; J. Mohler; D. Perkins; M. Markiewicz; R. Lieberman; G. Kelloff; M. Marshall; W. Grizzle
European Urology (1999) 35 (5-6): 429–438.
https://doi.org/10.1159/000019875
Factors Controlling the Expression of 5α-Reductase in Human Prostate: A Possible New Approach for the Treatment of Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 439–442.
https://doi.org/10.1159/000019876
Certain Aspects of Molecular Endocrinology That Relate to the Influence of Dietary Factors on the Pathogenesis of Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 443–455.
https://doi.org/10.1159/000019877
Preclinical Models for Drug Discovery
High-Grade Prostatic Intraepithelial Neoplasia in Dogs
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 456–458.
https://doi.org/10.1159/000019878
Use of Animal Models in Defining Efficacy of Chemoprevention Agents against Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 459–463.
https://doi.org/10.1159/000019879
Chemoprevention of Hormone-Dependent Prostate Cancer in the Wistar-Unilever Rat
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 464–467.
https://doi.org/10.1159/000019880
Surrogate Endpoint Biomarkers for Clinical Trials of Prostate Cancer Chemoprevention
Subtle Morphological and Molecular Changes in Normal-Looking Epithelium in Prostates with Prostatic Intraepithelial Neoplasia or Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 468–473.
https://doi.org/10.1159/000019881
Prostatic Intraepithelial Neoplasia: A Marker for High-Risk Groups and a Potential Target for Chemoprevention
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 474–478.
https://doi.org/10.1159/000019882
Genetic and Chromosomal Alterations in Prostatic Intraepithelial Neoplasia and Carcinoma Detected by Fluorescence in situ Hybridization
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 479–483.
https://doi.org/10.1159/000019883
Tissue Architecture Analysis in Prostate Cancer and Its Precursors: An Innovative Approach to Computerized Histometry
Subject Area:
Further Areas
Peter H. Bartels; Rodolfo Montironi; Vinicius Duval da Silva; Peter W. Hamilton; Deborah Thompson; Linda Vaught; Hubert G. Bartels
European Urology (1999) 35 (5-6): 484–491.
https://doi.org/10.1159/000019884
Reversibility of Prostatic Intraepithelial Neoplasia: Implications for Chemoprevention
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 492–495.
https://doi.org/10.1159/000019885
Evolution of Isolated High-Grade Prostate Intraepithelial Neoplasia in a Mediterranean Patient Population
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 496–497.
https://doi.org/10.1159/000019886
Clinical Evolution of Prostatic Intraepithelial Neoplasia
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 498–503.
https://doi.org/10.1159/000019887
PIN I–III: When Should We Interfere?
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 504–507.
https://doi.org/10.1159/000019888
Prostatic Intraepithelial Neoplasia and Endocrine Manipulation
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 508–510.
https://doi.org/10.1159/000019889
The Utility of Prostate-Specific Antigen as a Surrogate Marker for Identification of High-Risk Cohorts and Assessing Response in Chemoprevention Trials
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 511–514.
https://doi.org/10.1159/000019890
Clinical Trial Designs for Chemoprevention of Prostate Cancer
Practical Aspects of Clinical Trials on Chemoprevention of Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 515–518.
https://doi.org/10.1159/000019891
Statistical Considerations of Chemoprevention Clinical Trials in Prostate Cancer
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 519–522.
https://doi.org/10.1159/000019892
Prostate Cancer Screening in Tyrol, Austria: Experience and Results
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 523–538.
https://doi.org/10.1159/000019893
The European Randomized Study of Screening for Prostate Cancer (ERSPC): An Update
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 539–543.
https://doi.org/10.1159/000019894
Prostate Cancer Prevention Trial (PCPT) Update
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 544–547.
https://doi.org/10.1159/000019895
Index
Author Index Vol. 35, No. 5–6, 1999
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 548.
https://doi.org/10.1159/000019896
Subject Index Vol. 35, No. 5–6, 1999
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 549.
https://doi.org/10.1159/000019897
Further Section
Forthcoming Papers
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 550.
https://doi.org/10.1159/000019898
Acknowledgement to the Reviewers
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 551.
https://doi.org/10.1159/000019899
Index
Author Index Vol. 35, 1999
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 552–553.
https://doi.org/10.1159/000019900
Subject Index Vol. 35, 1999
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 554–556.
https://doi.org/10.1159/000019901
2.4 Curriculum in Urology: Infections and Stones
Prostatitis and Urethritis
Subject Area:
Further Areas
European Urology (1999) 35 (5-6): 557–566.
https://doi.org/10.1159/000019902
